Clinical Trials Directory

Trials / Unknown

UnknownNCT05928520

Pain Management in Pediatric Adenotonsillectomy

Comparison of Analgesic Efficacy of Topical Tramadol Versus Topical Lidocaine in the Control of Post Operative Pain in Children After Tonsillectomy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
4 Years – 15 Years
Healthy volunteers
Not accepted

Summary

Tonsillectomy is considered one of the most frequent minor surgeries conducted on a day-case basis on children, and usually associated with pain and sore throat. This study aimed to include 80 children, ASA physical status I\&II aged 4-15 years, and undergoing tonsillectomy. The purpose of this study is to determine the analgesic efficacy of topically applied lidocaine and tramadol in relieving post-operative pain in children following tonsillectomy.

Detailed description

Pain and sore throat following tonsillectomy are typical. As a result, the issue of adequate post-tonsillectomy pain management remains a significant therapeutic obstacle. Several medications, including nonsteroidal anti-inflammatory drugs, corticosteroids and narcotics have been utilised to alleviate pain following tonsillectomy. Nevertheless, they have numerous undesirable negative consequences. NSAIDs may impede hemostasis and increase the propensity for bleeding. Opioid may result in respiratory depression, nausea, and vomiting. Consequently, the major purpose of this study is pain alleviation with minimal adverse effects. This prospective, randomized, double-blind controlled clinical study will include 80 children, undergoing tonsillectomy, to receive either topical tramadol 5% or lidocaine 2%. Modified Visual Analogue Scale (m-VAS), bleeding, nausea, vomiting, sore throat, otalgia, fever, halitosis, and constipation will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGTramadol 5%Topical tramadol 5%
DRUGLidocaine 2%Topical Lidocaine 2%

Timeline

Start date
2023-08-01
Primary completion
2024-09-01
Completion
2024-10-01
First posted
2023-07-03
Last updated
2023-07-11

Source: ClinicalTrials.gov record NCT05928520. Inclusion in this directory is not an endorsement.